News for Sensus Healthcare, Inc. (SRTS)

Sensus Healthcare, Inc. (SRTS) reachead $4.72 at the closing of the latest trading day, reflecting a +1.51% change compared to its last close.

Sensus Healthcare, Inc. (SRTS) reachead $4.48 at the closing of the latest trading day, reflecting a +0.45% change compared to its last close.

Sensus Healthcare, Inc. (SRTS) closed the most recent trading day at $4.69, moving +1.08% from the previous trading session.

Sensus Healthcare, Inc. (SRTS) closed the most recent trading day at $4.78, moving +0.84% from the previous trading session.

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatmen

The average brokerage recommendation (ABR) for Sensus Healthcare (SRTS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatmen

Investors need to pay close attention to Sensus Healthcare (SRTS) stock based on the movements in the options market lately.

Q4 2024 showed a significant miss in profitability despite a 4% YoY sales growth; gross profit margin dropped due to a one-time discount for a new big client.

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 150 points on Thursday. The Dow traded down 0.35% to 44,715.15 while t...

U.S. stocks traded slightly higher this morning, with the Nasdaq Composite gaining around 0.2% on Thursday. Following the market opening Thursday, the Dow trad...

Pennsylvania-based Lipella Pharmaceuticals Inc. (LIPO), a clinical-stage biotechnology company is up over 180 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Earnings Call Insights: Sensus Healthcare (NASDAQ:SRTS) Q4 2024Management ViewJoe Sardano, Chairman and CEO, highlighted the company’s strong business...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2024 Earnings Conference Call February 5, 2025 4:30 PM ETCompany ParticipantsTirth Patel - Alliance Advisors, IRJoe...

Sensus Healthcare (SRTS) delivered earnings and revenue surprises of -10% and 32.59%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Sensus Healthcare (SRTS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Sensus Healthcare, Inc. (SRTS) closed at $6.92 in the latest trading session, marking a +1.91% move from the prior day.

We recently compiled a list of the 10 Under-the-Radar Stocks with Massive Upside for 2025. In this article, we are going to take a look at where Sensus Healthcare, Inc.

Sensus Healthcare, Inc. (SRTS) reachead $6.77 at the closing of the latest trading day, reflecting a +1.96% change compared to its last close.